Assessing the Case Against Direct-to-Consumer Drug Advertisements
Year: 2025
Type: article
Abstract: This Viewpoint assesses concerns regarding direct-to-consumer advertising of prescription drugs.
Source: JAMA Health Forum
Authors: Abby Alpert, Neeraj Sood
Language: English
Subfield: Pharmacology
Domain: Life Sciences
Open Access status: gold
Estimated APC paid: $5,000
OpenAlex ID: W4416211803
